BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 15102599)

  • 81. Mapping the minimal regions within the ORF73 protein required for herpesvirus saimiri episomal persistence.
    Griffiths R; Harrison SM; Macnab S; Whitehouse A
    J Gen Virol; 2008 Nov; 89(Pt 11):2843-2850. PubMed ID: 18931082
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Nanoparticle-mediated interleukin-12 cancer gene therapy.
    Hallaj-Nezhadi S; Lotfipour F; Dass C
    J Pharm Pharm Sci; 2010; 13(3):472-85. PubMed ID: 21092717
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Mutagenesis of the herpesvirus saimiri terminal repeat region reveals important elements for virus production.
    White RE; Carline L; Allday MJ
    J Virol; 2007 Jun; 81(12):6765-70. PubMed ID: 17428860
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Advances in high-capacity extrachromosomal vector technology: episomal maintenance, vector delivery, and transgene expression.
    Lufino MM; Edser PA; Wade-Martins R
    Mol Ther; 2008 Sep; 16(9):1525-38. PubMed ID: 18628754
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Gene delivery for cancer therapy.
    Zhang T
    Curr Drug Deliv; 2014; 11(2):233-42. PubMed ID: 24725018
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Human artificial chromosomes for gene delivery and the development of animal models.
    Kazuki Y; Oshimura M
    Mol Ther; 2011 Sep; 19(9):1591-601. PubMed ID: 21750534
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A novel micro-linear vector for in vitro and in vivo gene delivery and its application for EBV positive tumors.
    Wang HS; Chen ZJ; Zhang G; Ou XL; Yang XL; Wong CK; Giesy JP; Du J; Chen SY
    PLoS One; 2012; 7(10):e47159. PubMed ID: 23077563
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Recent progress of iron-based nanomaterials in gene delivery and tumor gene therapy.
    Gong Y; Hu X; Chen M; Wang J
    J Nanobiotechnology; 2024 Jun; 22(1):309. PubMed ID: 38825720
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Gene therapy for transplantation with viral vectors--how much of the promise has been realised?
    Tan PH; Tan PL; George AJ; Chan CL
    Expert Opin Biol Ther; 2006 Aug; 6(8):759-72. PubMed ID: 16856798
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Episomal vectors for gene therapy.
    Ehrhardt A; Haase R; Schepers A; Deutsch MJ; Lipps HJ; Baiker A
    Curr Gene Ther; 2008 Jun; 8(3):147-61. PubMed ID: 18537590
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Artificial viruses: exploiting viral trafficking for therapeutics.
    Glover DJ
    Infect Disord Drug Targets; 2012 Feb; 12(1):68-80. PubMed ID: 22034936
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Peptide-based gene delivery vectors.
    Kang Z; Meng Q; Liu K
    J Mater Chem B; 2019 Mar; 7(11):1824-1841. PubMed ID: 32255045
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Nonviral vectors.
    Louise C
    Methods Mol Biol; 2006; 333():201-26. PubMed ID: 16790853
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Nanotechnology-enabled gene delivery for cancer and other genetic diseases.
    Jiang T; Gonzalez KM; Cordova LE; Lu J
    Expert Opin Drug Deliv; 2023 Apr; 20(4):523-540. PubMed ID: 37017558
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Strategies on the nuclear-targeted delivery of genes.
    Yao J; Fan Y; Li Y; Huang L
    J Drug Target; 2013 Dec; 21(10):926-39. PubMed ID: 23964565
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Approaches and Recent Trends in Gene Delivery for Treatment of Atherosclerosis.
    Lalani R; Misra A; Amrutiya J; Patel H; Bhatt P; Patil SK
    Recent Pat Drug Deliv Formul; 2016; 10(2):141-55. PubMed ID: 26927413
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Current Landscape and Emerging Opportunities of Gene Therapy with Non-viral Episomal Vectors.
    Khan SU; Khan MU; Khan MI; Kalsoom F; Zahra A
    Curr Gene Ther; 2023; 23(2):135-147. PubMed ID: 36200188
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Strategies for the episomal modification of cells.
    Wong SP; Argyros O; Coutelle C; Harbottle RP
    Curr Opin Mol Ther; 2009 Aug; 11(4):433-41. PubMed ID: 19649988
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Protein/DNA polyplexes for gene therapy.
    Cristiano RJ
    Surg Oncol Clin N Am; 2002 Jul; 11(3):697-716, viii. PubMed ID: 12487063
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Plastic surgical delivery systems for targeted gene therapy.
    Ghali S; Dempsey MP; Jones DM; Grogan RH; Butler PE; Gurtner GC
    Ann Plast Surg; 2008 Mar; 60(3):323-32. PubMed ID: 18443515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.